Letaplimab represents a distinct medical approach for managing complement-mediated illnesses. This biologic targets the C1q protein, a essential molecule of the complement cascade, aiming to inhibit its early https://donnaipuu475556.blog5.net/92971610/letaplimab-a-groundbreaking-medical-strategy